Glenmede Trust’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-37
| Closed | -$4K | – | 2497 |
|
|
2020
Q3 | $4K | Buy |
37
+27
| +270% | +$2.92K | ﹤0.01% | 2169 |
|
|
2020
Q2 | $0 | Buy |
+10
| New | – | ﹤0.01% | 2698 |
|
|
2019
Q2 | – | Sell |
-12,760
| Closed | -$594 | – | 3231 |
|
|
2019
Q1 | $594 | Buy |
+12,760
| New | +$594 | ﹤0.01% | 853 |
|
|
2017
Q3 | – | Sell |
-13,186
| Closed | -$349K | – | 2884 |
|
|
2017
Q2 | $349K | Hold |
13,186
| – | – | ﹤0.01% | 1032 |
|
|
2017
Q1 | $349K | Hold |
13,186
| – | – | ﹤0.01% | 1032 |
|
|
2016
Q4 | $336K | Buy |
+13,186
| New | +$336K | ﹤0.01% | 1052 |
|
|
2015
Q4 | – | Sell |
-18,548
| Closed | -$461K | – | 2809 |
|
|
2015
Q3 | $461K | Hold |
18,548
| – | – | ﹤0.01% | 925 |
|
|
2015
Q2 | $586K | Buy |
18,548
+6,831
| +58% | +$216K | ﹤0.01% | 885 |
|
|
2015
Q1 | $445K | Hold |
11,717
| – | – | ﹤0.01% | 998 |
|
|
2014
Q4 | $456K | Buy |
11,717
+9,035
| +337% | +$352K | ﹤0.01% | 995 |
|
|
2014
Q3 | $81K | Hold |
2,682
| – | – | ﹤0.01% | 1544 |
|
|
2014
Q2 | $91K | Buy |
+2,682
| New | +$91K | ﹤0.01% | 1441 |
|